Loading...

Home
ETF
BCTX

BCTX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

BCTX News

BriaCell's Immunotherapy Study Receives Positive DSMB Recommendation

4d agoNASDAQ.COM

BriaCell's Phase 3 Study Receives Sixth Positive DSMB Recommendation

4d agoNewsfilter

BriaCell Reports Positive Clinical Data at ASCO 2026

May 22 2026Newsfilter

BriaCell Expands Focus on Women's Health with New Ovarian Cancer Therapy

May 15 2026Newsfilter

BriaCell Launches Next-Gen Immunotherapy for Prostate Cancer

May 14 2026Newsfilter

BriaCell's Phase 3 Clinical Trial Shows Significant Progress

May 12 2026Newsfilter

BriaCell Expands Clinical Trial Network with NYU Langone Health

May 07 2026Newsfilter

BriaCell Receives FDA Clearance for Clinical Study of Bria-BRES+

May 06 2026Newsfilter

BriaCell to Present Clinical Data at 2026 ASCO Annual Meeting

Apr 27 2026Newsfilter

Bria-OTS+ Platform Shows Promising Advances in Cancer Immunotherapy

Apr 21 2026Newsfilter

BriaCell Presents Positive Clinical Data at AACR 2026

Apr 20 2026Newsfilter

BriaCell to Present Four Research Abstracts at AACR Annual Meeting

Mar 10 2026Newsfilter

BriaCell and BriaPro Enter sCD80 Licensing Agreement

Feb 18 2026Newsfilter

BRIACELL AND BRIAPRO SIGN ASSET PURCHASE AGREEMENT FOR EXCLUSIVE LICENSE OF SOLUBLE CD80

Feb 18 2026moomoo

BriaCell's Phase 3 Study Receives Fifth Positive DSMB Recommendation

Feb 17 2026Newsfilter

BriaCell Treatment Shows Significant Efficacy in Cancer Patients

Jan 28 2026Newsfilter